Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.
Industry
Pharmaceutical Manufacturing, Scientific Research and Development Services, Services
HQ Location
19900 MacArthur Blvd
550
Irvine, California 92612, US
Keywords
biology and drugorgan and cellbroad therapeuticcellular transplantationorgan and cellularreleases governance stock